CN Stock MarketDetailed Quotes

Shanghai RAAS Blood Products (002252)

Watchlist
  • 5.56
  • +0.01+0.18%
Market Closed Apr 30 15:00 CST
36.91BMarket Cap27.80P/E (TTM)

Shanghai RAAS Blood Products (002252) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
进口白蛋白3.26B44.30%
Static propylene1.49B20.29%
自产白蛋白1.27B17.30%
Other blood products1.23B16.79%
检测设备及试剂87.84M1.20%
Other business8.43M0.11%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Production and sale of blood products7.25B98.69%
检测设备及试剂87.84M1.20%
Other operating income8.43M0.11%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region2.6B35.36%
North China2.09B28.50%
South China1.55B21.03%
Southwest area488.64M6.65%
Northwest region304.93M4.15%
Northeast area264.7M3.60%
Exit52.44M0.71%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More